Skip to content

Fund of VC Funds

Premium access to the world’s leading VC managers, with the eye of a direct investor

Through Aurora, our fund-of-funds arm, we invest in top-tier GPs across ICT and life sciences, giving our LPs curated exposure to the most dynamic segments of the venture market. As experienced direct VC investors, we bring that same lens to GP selection: accessing premium allocations, executing complex secondary transactions, and identifying winners others cannot reach.

Built on proprietary research

What sets us apart from traditional FoF managers is the combination of analytical depth and direct-investor judgment. We apply a bottom-up approach to identify and validate the best GPs, with particular focus on the Pan-European ecosystem, covering the EU, the UK, Israel, and the Nordics, and on life sciences, a cornerstone of our allocation.

This dual expertise enables us to deliver superior risk-adjusted returns while maintaining strong liquidity for our LPs.

Why Axon Fund of VC Funds?

  • Privileged access to global VCs, opened by over 20 years of direct investing.
  • A direct-investor lens applied to GP selection, established and emerging managers alike.
  • Disciplined portfolio construction with an optimised cash flow model.
  • Proven capability to execute complex secondary transactions.
  • Track record of superior risk-adjusted returns across cycles

Our multi-strategy approach combines primary investments, secondary transactions, and selective co-investments in portfolio winners, delivering a professionally managed, diversified portfolio built for institutional ambition.

Get in touch

News and insights

View more insights

Legal Information

Find out how we can support your ambitions

Get in touch

MENU